Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-908-9 | CAS number: 75-85-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-10-26 to 2011-11-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., Postbus 6174, 5960 AD Horst / The Netherlands
- Age at study initiation: pre-test: 10-11 weeks (beginning of treatment)
main study: 8-9 weeks (beginning of treatment)
- Weight at study initiation: 16.2 - 20.8 g
- Housing: Group
- Diet: Pelleted standard diet, ad libitum
- Water: Tap water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2°C
- Humidity (%): 45 – 65%
- Air changes (per hr): About 10 / hour
- Photoperiod (hrs dark / hrs light): Artificial light 6.00 a.m. - 6.00 p.m - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50, 100 %
- No. of animals per dose:
- 5 females per dose
- Details on study design:
- RANGE FINDING TESTS: a pre-test was performed in two animals .
- Treatment: topical application to the dorsal surface of each ear with test item concentrations of 50% (w/w) and 100% once daily each on three consecutive days.
- Systemic toxicity: At the tested concentrations the animals did not show any signs of systemic toxicity.
- Body weight: The animal treated with the undiluted test item showed loss of body weight of – 5.4%. Because no signs of systemic toxicity were observed in this animal, this was considered to be incidental.
- Irritation: On day 2 and day 3, the animal treated with the undiluted test item showed an erythema of the ear skin (Score 1). Other signs of irritation were not observed.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response:
a.) First, that exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the Stimulation Index.
b.) Second, that the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear with test item concentrations of 25, 50 (w/w), and 100% in acetone:olive oil (4+1 v/v). The application volume, 25 µL/ear/day, was spread over the entire dorsal surface of each ear once daily for three consecutive days. A further group of mice (control animals) was treated with an equivalent volume of the relevant vehicle alone. Five days after the first topical application (day 6) 250 µL of phosphate-buffered saline (PBS) containing 20.2 µCi of 3HTdR (equivalent to approximately 80.9 µCi/mL 3HTdR) were injected into each test and control mouse via the tail vein.
Approximately five hours after treatment with 3HTdR all mice were euthanised by intraperitoneal injection of Pentobarbital-Natrium. The draining lymph nodes were rapidly excised and pooled for each animal (2 nodes per animal). Single cell suspensions of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze. After washing two times with phosphate buffered saline the lymph node cells were resuspended in 5 % trichloroacetic acid and incubated at approximately +4°C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid (1 mL) and transferred to plastic scintillation vials with 10 mL of ‘Ultima Gold’ scintillation liquid and thoroughly mixed. The level of 3HTdR incorporation was then measured on a beta-scintillation counter. Similarly, background 3HTdR levels were also measured in two 1 mL-aliquots of 5 % trichloroacetic acid. The beta-scintillation counter expresses 3HTdR incorporation as the number of radioactive disintegrations per minute (DPM). The obtained DPM values were used to calculate stimulation indices (SI).
After excision, the lymph nodes were pooled per animal and weighed immediately using an analytical balance. Furthermore, the lymph node cell count was determined for each animal.
After the lymph nodes were excised, both ears of mice were punched at the apical area using a biopsy punch (Stiefel, Ø 8 mm corresponding to 0.5 cm2). For each animal both punches were immediately weighed (pooled per animal) using an analytical balance. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- A statistical analysis was conducted on the DPM values, the ear weights, the lymph node weights and the lymph node cell count to assess whether the difference was statistically significant between test item groups and negative control group. A One-Way-Analysis-of- Variance was used as statistical method. In case of significant results of the One-Way- ANOVA, multiple comparisons were performed with the Dunnett test. Statistical significance was set at the five per cent level (p < 0.05). However, both biological and statistical significance were considered together.
- Parameter:
- SI
- Remarks on result:
- other: 25 % 2-Methylbutan-2-ol: 1.6 * 50 % 2-Methylbutan-2-ol: 0.95 100 % 2-Methylbutan-2-ol: 1.13 * statistically significant increase vs. control group (p<0.05) The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Although a statistically significant increase in DPM value was observed in the low dose group in comparison to the vehicle control group, this was not considered as biologically relevant as the S.I. determined for this concentration did not exceed the threshold value of 3. Mean DPM - Background (1 mL 5% trichloroacetic acid): - Vehicle (acetone:olive oil (4+1 v/v)): 1127.8 +/- 321.4 - 25 % 2-Methylbutan-2-ol: 1800 +/- 383.5 - 50 % 2-Methylbutan-2-ol: 1075.4 +/- 281.3 - 100 % 2-Methylbutan-2-ol: 1274.6 +/- 263.4
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Viability / Mortality
No deaths occurred during the study period.
Clinical Signs
No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
Body Weights
The body weight of the animals, recorded after to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.
Lymph Node Weights and Cell Counts
The measured lymph node weights and –cell counts of all animals treated were recorded after sacrifice. A statistically significant or biologically relevant increase in lymph node weights and lymph node cell count was not observed in any of the test item treated groups in comparison to the vehicle control group. For BALB/c mice, a cutoff-value for the lymph node cell count index of 1.55 was reported for a positive response. The indices determined for the lymph node cell count did not exceed this threshold.
Ear Weights
The measured ear weights of all animals treated were recorded after sacrifice. A statistically significant or biologically relevant increase in ear weights was not observed in any treated group in comparison to the vehicle control group. For BALB/c mice, a threshold for the ear weight index of 1.1 was reported for a positive response. This threshold was not exceeded in any test item treated group.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a Local Lymph Node Assay according to OECD 429 guideline and GLP (Harlan CCR, 2012) mice (5 females/concentration) were treated with the test item at concentrations of 25, 50 and 100 % (w/v) and with an equivalent volume of the relevant vehicle (acetone/olive oil 4:1 (v/v)) alone. A further group of mice were treated with the positive control (25 % alpha-Hexylcinnamaldehyde). Each substance was applied on the external surface of each ear (25 µL/ear) of the animals for three consecutive days (Day 1, 2 and 3). There was no treatment on Days 4, 5 and 6. On Day 6 animals were intravenously injected via the tail vein with tritiated methyl thymidine (3HTdR), than sacrificed approximately 5 hours after the injection. The draining lymph nodes were removed and processed (individual approach, 2 nodes per animal). The cell proliferation in the local lymph nodes was measured by incorporation of 3HTdR via an beta-scintillation counter and expressed as the number of radioactive disintegrations per minute (DPM). The obtained DPM values were used to calculate stimulation indices (SI). Ear punch weight was measured at sacrifice. No mortality was observed during the test. No signs of systemic toxicity and no test item related effect on body weight gain occurred.The measured ear punch weight values did not revealed an increased ear weight in any treated group in comparison to the vehicle control group. A statistically significant or biologically relevant increase in lymph node weights and lymph node cell count was not observed in any of the test item treated groups in comparison to the vehicle control group. For BALB/c mice, a cutoff-value for the lymph node cell count index of 1.55 was reported for a positive response. The indices determined for the lymph node cell count did not exceed this threshold. The SI values were 1.6, 0.95 and 1.13 at concentrations of 25 %, 50 % and 100 %, respectively. No dose-related response was observed. Under the conditions of the present Local Lymph Node Assay, 2-Methylbutan-2-ol was shown to have no sensitization potential.
In a second test (Clayton and Clayton, 1982) skin sensitization was determined according to the Maguire method in guinea pigs. 10 animals were treated with undiluted 2-Methyl-2-butanol and 10 further animals were tested with a positive control. No sensitizing effects were observed in the animals treated with the test item, whereas the positive control group revealed the expected positive response. The results of the present study are in line with the results obtained in the key study.
Migrated from Short description of key information:
2-Methylbutan-2-ol is not skin sensitising.
Justification for selection of skin sensitisation endpoint:
Most reliable study
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results obtained in the skin sensitisation test, 2 -Methylbutan-2 -ol is not subject to classification for sensitization according to Directive 67/548/EEC and according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.